Search Results 31-40 of 17438 for triple negative breast cancer

1. Multi-epitope Folate Receptor Alpha Peptide Vaccine, Sargramostim, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer - Mayo Clinic

   ... triple negative breast cancer. Vaccines made from a person's white blood cells mixed with tumor proteins may help the body build an effective immune ...

2. Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) - Mayo Clinic

   ... Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) ... breast cancer (TNMBC) or metastatic triple negative breast cancer ...

3. TUESDAY Q & A: Treatment plan should be based on specific type of breast cancer

   Finally, the last group of breast cancers are characterized by the lack of expression of all three receptors (ER and HER2), or triple negative breast cancer.

4. Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer - Mayo Clinic

   ... triple negative breast cancer that has spread to other parts of the body. Monoclonal antibodies, such as pembrolizumab, may block tumor growth in different ...

5. Breast Cancer Clinical Trials

   The primary purpose of this study is to examine the effects of abemaciclib on the CD8/FOXP3 ratio in chemotherapy-resistant triple negative breast cancer (TNBC) ...

6. The BEAUTY of it: award recognizes personalized medicine approach for breast cancer - Mayo Clinic News Network

   ... triple negative breast cancer. "These new discoveries can lead to more clinical trials that will provide additional choices for personalized care," says Dr ...

7. Olaparib and Atezolizumab Either Alone or in Combination in Treating Patients With Stage III-IV Triple Negative Breast Cancer - Mayo Clinic

   ... triple negative breast cancer. Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies ...

8. Estrogen receptor mRNA directed therapy for triple negative breast cancer

   Introduction: Patients with TNBC do not respond to hormone therapy, and therefore are limited to chemotherapeutic treatment regimens.

9. Breast cancer: Predicting individual risk - Mayo Clinic News Network

   Although it makes up only 12 percent of all cases, triple-negative breast cancer is the most aggressive form of the disease and is difficult to treat because ...

10. Testing the Addition of an Anti-cancer Drug, ASTX727, to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer - Mayo Clinic

    Testing the Addition of an Anti-cancer Drug, ASTX727, to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast ...